Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.1%

151 terminated/withdrawn out of 791 trials

Success Rate

73.7%

-12.8% vs industry average

Late-Stage Pipeline

13%

104 trials in Phase 3/4

Results Transparency

57%

243 of 423 completed trials have results

Key Signals

114 recruiting243 with results86 terminated65 withdrawn

Enrollment Performance

Analytics

N/A

352(51.8%)

Phase 2

112(16.5%)

Phase 4

85(12.5%)

Phase 1

81(11.9%)

Early Phase 1

31(4.6%)

Phase 3

19(2.8%)

680Total

N/A(352)

Phase 2(112)

Phase 4(85)

Phase 1(81)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (791)

Showing 20 of 791 trials

NCT03188705Phase 4Completed

CES1 Carriers in the PAPI Study

Role: lead

NCT07730177Phase 1Not Yet Recruiting

Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Role: collaborator

NCT07244211Not ApplicableRecruiting

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Role: collaborator

NCT05397119Phase 1Completed

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Role: collaborator

NCT07735520Not ApplicableNot Yet Recruiting

Feasibility and Acceptability of OLP-EXP in Chronic Pain

Role: lead

NCT05817370Not ApplicableRecruiting

Implementation of Anal Cancer Screening and Treatment in Nigeria

Role: lead

NCT07528430Not Yet Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

Role: lead

NCT07153029Not ApplicableCompleted

Older Adults, Methadone, and Cognitive Function

Role: lead

NCT07008664Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

Role: lead

NCT07221708Phase 2Withdrawn

Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin

Role: lead

NCT06864936Not ApplicableRecruiting

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Role: lead

NCT04416412Completed

ICG Fluorescence Imaging in Open Fracture Trauma Patients

Role: collaborator

NCT06199154Early Phase 1Recruiting

Induction of Labor in Morbidly Obese Patients

Role: lead

NCT04520698Not ApplicableCompleted

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

Role: collaborator

NCT07378800Not ApplicableActive Not Recruiting

Fostering Positive Care Interactions in Assisted Living

Role: lead

NCT05511909Phase 2Recruiting

Evaluating Buspirone to Treat Opioid Withdrawal

Role: lead

NCT01712620Phase 2Recruiting

Spironolactone for Pulmonary Arterial Hypertension

Role: collaborator

NCT07014098Not ApplicableNot Yet Recruiting

Robot-Aided Off-Axis Neuromuscular Training for Knee OA

Role: lead

NCT05071898Phase 1Recruiting

Pharmacogenetics of Response to GLP1R Agonists

Role: lead

NCT05109429Not ApplicableCompleted

Developing a Clinical Outcome Assessment for Opioid Craving

Role: lead